ClassID:

94289

C07D215/58 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom

Sub-classes:
Recent Application in this class:
#1
20250214941
2025-07-03

ORGANIC COMPOUND (OXIME) TO COMBAT CHEMICAL WARFARE AGENTS

#2
20240300899
2024-09-12

A QUINOLONE COMPOUND IN SOLID FORMS AND PROCESSES FOR THE PREPARATION THEREOF

#3
20240190823
2024-06-13

NRF2 INHIBITORS AND USES THEREOF

#4
20230339879
2023-10-26

SUBSTITUTED CHROMANES, ANALOGS THEREOF, AND METHODS OF USE AND SYNTHESIS

#5
20230278971
2023-09-07

COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES

#6
20230190730
2023-06-22

4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT

#7
20230142739
2023-05-11

PROTEIN-PROTEIN INTERACTION STABILIZERS

#8
20230110928
2023-04-13

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#9
20220396549
2022-12-15

SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEROF

#10
20220267275
2022-08-25

Inhibitors of influenza viral entry

#11
20220259222
2022-08-18

MK2 inhibitors, the synthesis thereof, and intermediates thereto

#12
20220127206
2022-04-28

METHOD FOR INTRODUCING DEUTERATED LOWER ALKYL INTO AMINE MOIETY OF COMPOUND CONTAINING SECONDARY AMINE

#13
20210363098
2021-11-25

Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation

#14
20210309622
2021-10-07

COMPOUNDS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES

#15
20210188835
2021-06-24

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

#16
20210061778
2021-03-04

Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#17
20210009547
2021-01-14

Substituted chromanes, analogs thereof, and methods of use and synthesis

#18
20200392095
2020-12-17

Compounds affecting pigment production and methods for treatment of bacterial diseases

#19
20200239454
2020-07-30

Sulfonyl substituted bicyclic compound which acts as ROR inhibitor

#20
20200101061
2020-04-02

4-OXOQUINOLINE COMPOUND AND USE THEREOF AS PHARMACEUTICAL AGENT

#21
20200024268
2020-01-23

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#22
20190359574
2019-11-28

Process for the preparation of quinolone based compounds

#23
20190292159
2019-09-26

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

#24
20190210998
2019-07-11

Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof

#25
20190135768
2019-05-09

Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#26
20180305347
2018-10-25

METHODS AND COMPOSITIONS USEFUL IN TREATING CANCER AND REDUCING WNT MEDIATED EFFECTS IN A CELL

#27
20180265502
2018-09-20

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#28
20180208587
2018-07-26

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#29
20180208554
2018-07-26

Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof

#30
20180186744
2018-07-05

Compounds for inhibiting c-myc/max/DNA complex formation

#31
20180072677
2018-03-15

Peptidomimetics and methods of using the same

#32
20180030005
2018-02-01

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

#33
20180029988
2018-02-01

Compounds for inhibiting c-Myc/Max/DNA complex formation

#34
20170305904
2017-10-26

Compounds for inhibiting drug-resistant strains of HIV-1 integrase

#35
20170275301
2017-09-28

Benzenesulfonyl-asymmetric ureas and medical uses thereof

#36
20170183331
2017-06-29

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease

#37
20170066755
2017-03-09

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#38
20160318870
2016-11-03

RORγ modulators

#39
20160304476
2016-10-20

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

#40
20160229844
2016-08-11

RORγ modulators

#41
20160083382
2016-03-24

Compounds for inhibiting drug-resistant strains of HIV-1 integrase

#42
20150299193
2015-10-22

Quinolone derivatives

#43
20150284401
2015-10-08

Chiral fluorinating reagents

#44
20150157705
2015-06-11

Three-dimensional cavities of dendritic cell immunoreceptor (DCIR), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (HIV-1)

#45
20150051177
2015-02-19

Methods and compositions useful in treating cancer and reducing WNT mediated effects in a cell

#46
20140128397
2014-05-08

Synthetic lethal targeting of glucose transport

#47
20140088094
2014-03-27

N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

#48
20140038883
2014-02-06

NOVEL AZACOUMARIN DERIVATIVES HAVING MDR PUMP INHIBITING ACTIVITY

#49
20130172344
2013-07-04

4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR

#50
20130150392
2013-06-13

Iminopropene compound and use thereof

#51
20120237874
2012-09-20

Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition

#52
20120142729
2012-06-07

KAT II inhibitors

#53
20120071466
2012-03-22

Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1

#54
20120046250
2012-02-23

Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell

#55
20110319437
2011-12-29

Iminopropene compound and use thereof

#56
20110200935
2011-08-18

Photoresist composition

#57
20110111959
2011-05-12

Pollen tube stimulants from pistils

#58
20110053915
2011-03-03

Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system

#59
20110039808
2011-02-17

Multitarget Compounds Active at a PPAR and Cannabinoid Receptor

#60
20110027716
2011-02-03

ACTINIC-RAY- OR RADIATION-SENSITIVE RESIN COMPOSITION, COMPOUND AND METHOD OF FORMING PATTERN USING THE COMPOSITION

#61
20100179119
2010-07-15

Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold

#62
20100168112
2010-07-01

2-Substituted and 4-substituted aryl nitrone compounds

#63
20100152165
2010-06-17

CARBOXYLIC ACID DERIVATIVES

#64
20100144742
2010-06-10

Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

#65
20100016293
2010-01-21

Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use

#66
20090075975
2009-03-19

Arylsulfonamides and uses related thereto

#67
20090030013
2009-01-29

Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments

#68
20090021160
2009-01-22

MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, METHOD FOR PRODUCING SAME AND ORGANIC ELECTROLUMINESCENT DEVICE

#69
20080153859
2008-06-26

MULTIPLY-SUBSTITUTED TETRAHYDRONAPHTHALENE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS

#70
20080153805
2008-06-26

Sulfonamide derivatives

#71
20080004323
2008-01-03

Iminopropene compound and use thereof

#72
20070099960
2007-05-03

LXR receptor modulators

#73
20070060567
2007-03-15

Indolyl derivatives which are L-CPT1 inhibitors

#74
20060247229
2006-11-02

Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides

#75
20060223829
2006-10-05

Hydroxysteroid dehydrogenase inhibitors

#76
20060217413
2006-09-28

4-oxoquinoline compound and use thereof as HIV integrase inhibitor

#77
20060167244
2006-07-27

Polymerisation inhibitor

#78
20060167046
2006-07-27

Histamine h3 receptor antagonists, preparation and therapeutic uses

#79
20060079557
2006-04-13

Sulfamoyl benzamide derivatives and methods of their use

#80
20060063820
2006-03-23

2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties

#81
20060035884
2006-02-16

N-cyclic sulfonamido inhibitors of gamma secretase

#82
20050288271
2005-12-29

Arylsulfonamides and uses related thereto

#83
20050239819
2005-10-27

4-oxoquinoline compound and use thereof as pharmaceutical agent

#84
20050234044
2005-10-20

Cyclic amine derivatives and methods of use

#85
20050182060
2005-08-18

2-Substituted and 4-substituted aryl nitrone compounds

#86
20050113450
2005-05-26

Antibacterial agents